Where do immunotherapies stand in management of acute leukemia in adults?

Immunotherapies have significantly transformed the treatment landscape of acute leukemia in adults, most notably in B-cell acute lymphoblastic leukemia (B-ALL). Blinatumomab and inotuzumab ozogamicin have become established treatments, enhancing remi…

Preview only. Read the full abstract at the source